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Abstract 
Aim:  
Investigate whether native-T1 mapping can assess the transmural extent of myocardial 
infarction(TEI) thereby differentiating viable from non-viable myocardium without the use 
of gadolinium-contrast in both acute and chronic myocardial infarction(aMI and cMI). 
METHODS: 
60patients (30 cMI>1year and 30 aMI day2 STEMI) and 20 healthy-controls underwent 1.5T 
CMR to assess left ventricular function(cine), native-T1 mapping(MOLLI sequence 5(3)3, 
motion-corrected) and the presence and TEI from late gadolinium enhancement(LGE) 
images. Segments with <75% TEI was considered viable.  Gold-standard LGE-TEI was 
compared with corresponding segmental native-T1.  
 
RESULTS: 
Segmental native-T1 correlated significantly with TEI(R= 0.74,p<0.001 in cMI and 
R=0.57,p<0.001 in aMI). Native-T1 differentiated segments with no LGE(1031±31ms), LGE 
positive but viable(1103±57ms) and LGE positive but non-viable(1206±118ms) in 
cMI(p<0.01). It also differentiated segments with no LGE(1054±65m), LGE positive but 
viable(1135±73ms) and LGE positive but non-viable(1168±71ms) in aMI(p<0.01). ROC 
analysis demonstrated excellent accuracy of native-T1 mapping compared to LGE-TEI(AUC-
0.88,p <0.001 in cMI, vs AUC –0.83,p<0.001 in aMI). Native-T1 performed better in cMI than 
aMI(p<0.01). In cMI a segmental T1 threshold of 1085ms differentiated viable from non-
viable segments with a sensitivity 88% and specificity of 88% whereas a T1 of 1110ms 
differentiated viable from nonviable with 79% sensitivity and 79% specificity in aMI.  
  
CONCLUSIONS: 
Native-T1 mapping correlates significantly with TEI thereby differentiating between normal, 
viable, and non-viable myocardium with distinctive T1 profiles in aMI and cMI. Native T1-
mapping to detect MI performed better in cMI compared to aMI due to absence of 
myocardial oedema. Native-T1 mapping holds promise for viability assessment without the 
need for gadolinium-contrast agent. 
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Introduction 
Acute myocardial infarction leads to reversible (viable/stunned) and irreversible(non-viable) 
myocardial injury, even after successful coronary reperfusion. Early recognition of viable 
myocardium after a myocardial infarction(MI) is of clinical relevance as the affected 
segments have the potential for recovery. Targeted revascularization of viable myocardium 
improves clinical outcomes. Hence viability assessment is a key aspect in the management 
of ischaemic heart disease (IHD). Late gadolinium enhancement (LGE) CMR is increasingly 
used in clinical practice as a viability assessment tool (1,2). LGE viability assessment is 
performed by analyzing the extent of scar thickness, with a myocardial segment 75% 
transmurality deemed mostly non viable. The transmural extent of infarct (TEI) assessed by 
LGE has been shown to be inversely related to functional recovery  after reperfusion (3,4).  
LGE imaging requires administration of gadolinium-based contrast agents. The use of these 
contrast agents is limited in patients with moderate to severe renal dysfunction due to the 
potential risk of nephrogenic systemic fibrosis.(5) In addition there have been several 
reports of gadolinium-based deposits in the central nervous system structures following 
repeated use of gadolinium contrast, whose clinical meaning is still uncertain. (6) An 
alternative viability imaging method that might obviate the use of contrast-agents is 
desirable.  
Myocardial T1 mapping is emerging as a novel non-contrast CMR imaging tool in the 
assessment of non-IHD and IHD (7). Native T1 mapping technique is highly sensitive to 
changes in myocardial tissue, thereby providing excellent tissue characterization obviating 
for the need for contrast administration. Kali et al. looked at diagnostic accuracy of T1-
mapping in the detection of overall transmurality in chronic MI using a thresholding-based 
detection.(8) We tested the hypothesis that native segmental T1 mapping can assess the TEI 
  
thereby differentiating between viable and non-viable myocardium in IHD without the use 
of gadolinium contrast. 
 
Aim: 
The aim of the study was to compare the performance of native segmental T1 mapping in 
quantifying the TEI/myocardial scarring with LGE in chronic as well as acute MI patients 
using a 1.5T CMR.  
 
Methods:  
Study population 
60 patients with myocardial infarction were recruited: 30 successfully re-perfused STEMI 
patients (mean age 61±10years and 80% males) scanned at day 2 and 30 chronic MI patients 
(>1year after MI) (mean age 67±10years and 80% males). All patients were diagnosed with 
MI according to guidelines. (9,10) Exclusion criteria were: general contraindications to CMR, 
chronic atrial fibrillation, renal impairment with eGFR <30, and cardiogenic shock. 20 age‐ 
and sex‐matched healthy volunteers served as control (all free of cardiovascular disease). 
The study was approved by the local Institutional Research and Innovation department. All 
patients gave informed written consent. Findings were compared with 20 healthy volunteers 
with no previous medical history (mean age 59±16yrs, 75% male). 
 
Image acquisition 
Patients underwent CMR scans on a 1.5-T scanner (Magnetom Avanto, Siemens) with a 
standard 8-channel matrix coil configuration.  
  
The imaging protocol consisted of three long-axis (four-, three-, and two-chamber view) and 
a full stack of short-axis steady-state free precession cine images as previously described. 
(11) This was followed by the acquisition of three short-axis slices (basal, mid-cavity, and 
apical) by using T1mapping sequence (details of the sequence provided below). 
Subsequently, acquisition of the same three short-axis slices (basal, mid-cavity, and apical) 
was repeated by using a segmented inversion-recovery gradient-echo sequence (IR-GRE) 1–
3 minutes after the intravenous administration of 0.1 mmol/kg of gadobutrol (Gadovist; 
Bayer Schering Pharma, Berlin-Wedding, Germany) (early gadolinium enhancement EGE). 
Late gadolinium enhancement (LGE) images were acquired 15-20 minutes after contrast 
agent injection in the three long-axis and the full stack of short-axis views. (12) In acute MI 
cohort T2weighted STIR(short tau inversion recovery) images were acquired on short-axis 
planes covering the entire left ventricle prior to gadolinium administration.  
 
Late gadolinium enhancement imaging 
Images were acquired at least 15 min following administration of 0.1 mmol/kg gadobutrol. 
LGE images were obtained using an inversion recovery prepared breath-hold gradient-echo 
technique. Typical image parameters were TR 700 ms, TE 4.33 ms; matrix 256 × 256; flip 
angle 30°; slice thickness 8.0 mm, no interslice gap, and voxel size 1.7 × 1.4 × 8 mm. The 
inversion time was progressively optimized to null normal myocardium (typical values, 250–
350 ms). Images were acquired on both the long- and short-axis planes covering the entire 
left ventricle. Each slice was obtained during a breath-hold of 10–15 s depending on the 
patient's heart rate 
 
T1 mapping sequence 
  
Myocardial T1-mapping was performed using the modified Look-Locker inversion recovery 
(MOLLI) sequence 5(3)3 (Siemens Healthcare, Germany). The 5(3)3 MOLLI protocol was 
used to ensure more‐complete recovery of the inversion pulse at higher heart rates by 
acquiring a set of images for at least 5 seconds after the first inversion pulse, followed by a 
3‐second pause and then acquiring a set of images after the second inversion pulse for at 
least 3 seconds. The acquisition parameters were: pixel bandwidth, 977 Hz/pixel; echo 
time=1.12 ms; flip angle=35 degrees; matrix=256×144; and 8 mm slice thickness. A 
nonlinear least‐square curve fitting and motion correction were performed at different 
inversion times with the set of images acquired to generate a pixel‐wise colored T1 map by 
the scanner.(13) 
 
T2w STIR 
A breath-hold black-blood segmented turbo spin echo sequence was adopted for T2w STIR 
imaging, using a triple inversion recovery preparation module in order to suppress signal 
from flowing blood as well as from fat, with surface coil normalization. (14)  Typical 
imaging parameters were TR 2 R-to-R intervals, TE 75 ms, flip angle 90°, TI 170 ms, slice 
thickness 8 mm, no interslice gap, field of view 340–400 mm, matrix 208 × 256, and a voxel 
size of 2.3 × 1.4 × 8 mm. Each slice was obtained during a breath-hold of 10–15 s depending 
on the patient's heart rate.  To accommodate poor breath-holders, turbo factor was increased 
as necessary. 
 
Image analysis 
Argus software (Siemens, Germany) was used for the quantification of LV volumes and 
ejection fraction (EF) (15). Segmental TEI was assessed by contouring the area of LGE and 
  
dividing it by the area of the whole segment using full width at half maximum(FWHM) 
technique using CVI42 software (Circle Cardiovascular Imaging, Calgary, Alberta, Canada). 
A scar transmurality scale of 0-4 was used for the 16 AHA segment (0=no scar, 1= 1-24%, 
2=25-49%, 3=50-74%s and 4=≥75% scar thickness). A scar transmurality grade of 3 or less 
(<75% TEI) was deemed viable. (3,16) Observer blinded to the LGE data(AGD) drew regions 
of interest within the native T1 map in each of the American Heart Association (AHA) 16 
segments in the short axis motion corrected maps using Argus software, adjusting for 
partial-voluming and/or artefact, as previously described. (17) Figure 1 The LGE data was 
blinded for the T1 mapping analysis in order to test the hypothesis that T1 mapping can 
assess viability without the need of LGE.  Images were randomized for analysis. In patients 
with acute MI, the hypointense areas in the LGE images (representing MVO), when present, 
were included in the contoured areas for the segment wise calculation of TEI. The infarct 
size was calculated from the LGE images by semi-automated software based analysis 
(FWHM) and expressed in % of the total LV volume. Another observer drew ROIs (GP) in the 
infarct core and remote myocardium in the T1 maps corresponding to the LGE 
image(unblinded).  Remote myocardium was defined as myocardial tissue 180degree to the 
infarct with no evidence of hyperenhancement or myocardial oedema, as previously 
described.(18) Analysis was also done as per the coronary artery territory. Myocardial 
segments were assigned to coronary arteries as described in the AHA 16 segment 
model(excluding the apical cap), with 6 segments for the left anterior descending artery, 5 
for the right coronary artery, and 5 for the left circumflex artery. (19) In each patient ‘global 
native T1’ was derived by taking the mean T1 of all 16 AHA segments. Images were 
suboptimal/non diagnostic if there was artefact or signal loss that interfered with the ability 
of the observers to interpret the image. This was observed in 3 patients but to overcome 
  
the problem the sequences were repeated. In the final analysis no images were considered 
non-diagnostic. 
 
Statistical analysis 
Statistical analysis was performed using SPSS V.23 (Armonk, New York, USA: IBM Corp.) and 
R version 3.1.2 (R Core Team 2014). Categorical variables were analyzed using Fisher exact 
tests. Normally distributed continuous variables were expressed as mean±standard 
deviation and compared using unpaired Student t tests or one-way analysis of variance with 
Bonferroni post hoc correction for between-groups comparisons, as appropriate. 
Continuous variables that were not normally distributed were compared by Kruskal–Wallis 
tests. R-values quoted are for Pearson's correlation coefficient. The potential of quantitative 
T1-mapping to assess the TEI or viability on a segmental basis against the current gold 
standards of LGE were explored. The analysis was also performed as per each coronary 
artery territory. Interobserver (AGD and IH) and intraobserver (AGD) variability for 
segmental native T1 was assessed in 20 patients (10 acute MI and 10 chronic MI patients), 
and expressed as intraclass correlation coefficient (ICC) and 95% confidence interval.  
 
Segmental analysis run a risk of class effect due to the potential of multiple samples from 
the same patient. To nullify the class-effect a series of generalized linear mixed effect 
models, with the random intercept for each person and for each segment, were performed 
to assess the association between T1 mapping and viability/LGE TEI. The models were used 
to account for the fact that different segments from the same patient or same segment 
location from different patients may not behave independently. These models were 
conducted for both acute and chronic MI assessments. Receiver operating characteristic 
  
(ROC) analysis was performed to identify area under curve (diagnostic accuracy) of native T1 
as a marker of TEI by using corresponding LGE scoring (LGE score >3) as the gold standard. 
Cut-off values of T1 relaxation times as a marker of viability were also calculated from the 
ROC curve. Statistical significance of the differences between ROC curves was assessed 
using the online calculator (www.vassarstats.net).  To take into consideration potential 
within-subject interaction of segments, clustered ROC analysis was also conducted to assess 
the performance of native T1 to predict viability. Significance was defined as two-tailed 
p<0.05. 
 
Results:  
The demographic and the CMR characteristics of the healthy control and the patient cohort 
(60 MI patients- acute and chronic MI subgroups) are presented in Table 1. The mean age of 
the healthy volunteers was 57±13yrs and 75% were male. The mean age was significantly 
lower in the acute MI group (61±10yrs vs 67±10yrs, p=0.017) compared to the chronic MI 
group. In 5%(n=3) of patients the T1 maps had artefacts or signal. To overcome this 
problem, the mapping images were repeated. Out of the 960 segments analysed from 
patients with previous MI(acute and chronic), 286 segments had evidence of LGE. Sixteen of 
the 30 acute MI patients had microvascular obstruction (MVO) (53%).  
 
Interobserver and intraobserver variability for segmental T1 measurement 
There was excellent inter and intra-observer agreement for native segmental T1 
measurement. The intraclass correlation coefficient (ICC) and 95% confidence interval were 
  
0.968 (0.958-0.976) for interobserver and 0.992(0.967-0.998) for intraobserver agreement 
respectively. 
Chronic MI 
T1 mapping vs scar transmurality (TEI)-In patients with chronic MI, the segmental T1 
correlated significantly with LGE TEI (R= 0.74, p<0.001). Figure 2a. The mean segmental T1 
value for LGE negative segments (myocardial segments with no infarction) was 1,031±31ms, 
LGE positive but viable (scar grade 1-3): 1,103±57ms and LGE positive but non viable (scar 
grade 4): 1206±118ms. The mean segmental T1 in each of the 3 categories (no LGE, LGE 
positive but viable and LGE positive but non-viable) were significantly different on a pairwise 
comparison with Bonferroni correction (p<0.01). Figure 2b The mean native T1 in the infarct 
core and remote myocardium were 1171±76ms and 1005±19ms respectively. Table 2 
When grouping the segments into coronary artery territories, the correlation between 
native T1 and LGE TEI for RCA, LCx and LAD territories were R=0.77, 0.80, 0.69 
respectively(p<0.001). Figure 2c  
T1 mapping as a marker of transmurality of infarction -Native T1 mapping showed 
excellent diagnostic accuracy in predicting transmural LGE≥75% - AUC-0.88(CI 0.77- 0.99,p 
<0.001). Figure 2d  A cut-off of native T1 of 1,085ms differentiated viable from non-viable 
segments with 88% sensitivity and 88% specificity. Clustered ROC curve analysis showed 
that segmental T1 mapping had an AUC of 0.8338 (95% CI 0.7002-1.00) to predict viability.  
Mixed effects model with random intercept - Generalized linear mixed effect models, with 
the random intercept to assess the association between native T1 and viability/TEI 
correcting for the class effect due to multiple segments from same person or same segment 
location. Presence of non viability was significantly associated with native T1 (Chi square 
  
307.02, p < 0.01), increasing it by 131.9 ± 6.3ms (standard errors). TEI significantly affected 
T1 (Chi square 388.9, p< 0.01), increasing it by 2.07± 0.1ms (standard errors) for every 
percent increase in TE.  
 
Acute MI 
T1 mapping vs scar transmurality (TEI)- In patients with acute MI, the segmental T1 
correlated significantly with LGE TEI with R= 0.57, p<0.001. Figure 3a The mean segmental 
T1 value for scar transmurality grade 0 (no LGE) was 1,054±65ms, LGE positive but viable 
(scar grade 1-3): 1,135±73ms and LGE positive but non viable (scar grade 4): 1,168±71ms. 
The mean segmental T1 in the 3 categories (no LGE, LGE positive but viable and LGE positive 
but non-viable) were significantly different on a pairwise comparison with Bonferroni 
correction (p<0.01). Figure 3b The mean native T1 in the infarct core and remote 
myocardium were 1308±71ms and 1054±65ms respectively Table 2. 
When grouping the segments into coronary artery territories, the correlation between 
native T1 and LGE TEI for RCA, LCx and LAD territories were R=0.66, 0.57, 0.57 
respectively(p<0.001). Figure 3c 
T1 mapping as a marker of transmurality of infarction - ROC analysis of segmental native 
T1 in acute MI against gold standard LGE viability(>75%TEI) showed good diagnostic 
accuracy AUC-0.83(CI 0.78- 0.88, p<0.001). Figure 3d. A T1 threshold of 1110ms most 
optimally differentiated viable from non-viable segments with 79% sensitivity and 79% 
specificity. Clustered ROC curve analysis showed that segmental T1 mapping had an AUC of 
0.8338 (95% CI 0.7587-0.9088) to predict viability.  
 
  
Mixed effects model with random intercept -Presence of non viability was significantly 
associated with native T1 (Chi square 145.4, p < 0.01), increasing it by 100.1 ± 7.7ms 
(standard errors). TEI significantly affected native T1 (Chi square 206.1, p=< 0.01), increasing 
it by 1.5± 0.1ms (standard errors) for every percent increase in TEI. 
T2w STIR area at risk (oedematous area) in acute MI- All the acute MI scans showed 
evidence of myocardial oedema in the infarct related artery territory. The area at risk (total 
area of oedema) in the acute MI was 31±12% of the total LV.                                             
                                                           Global native T1 
Global native T1 in normal vs affected - Global native T1 in normal healthy volunteers was 
compared with all patients with previous MI (acute and chronic). The mean global T1 in 
normal volunteers was 1028±28ms, which was significantly lower than patients with 
previous MI 1070±36ms, p<0.0001. The global native T1 in patients with acute MI was 
1082±34ms (p<0.0001 vs normal volunteer), whereas for chronic MI it was 
1058±34ms(p=0.002 vs normal volunteer). Figure 4 
 
Global native T1 vs Infarct size - Global native T1 was compared with the infarct size. For 
the total cohort (n=60) it showed a good positive correlation r= 0.575, p<0.001. Subgroup 
analysis: the correlation was found to be excellent in chronic MI r=0.717, p<0.001 whereas 
for acute MI it was weakly significant r=0.365, p=0.048 (Figure 5a).  
Global native T1 vs LV EF -Global native T1 was compared with the left ventricular ejection 
fraction. For the total cohort (n=60) it showed a significant inverse correlation r= -0.445, 
p<0.001. Subgroup analysis: the correlation was found to be statistically significant in 
chronic MI r=-0.596, p<0.001 but not in acute MI r=-0.291, p=0.118. Figure 5b 
  
 
T1 mapping vs wall motion score vs wall thickness for the assessment of viability 
Segmental native T1 was compared with segmental wall thickness and segmental wall 
motion score against gold standard LGE viability. ROC analysis of the 960 segments for 
viability assessment showed the highest diagnostic accuracy of T1 mapping (AUC - 0.9, 
95%CI 0.87- 0.93, p <0.0001) when compared to wall motion score (AUC 0.837, p<0.0001, 
95%CI 0.8-0.875), and segmental wall thickness (AUC 0.453, p=0.07, 95%CI 0.401-0.505).  
 
Discussion 
The study looked at the diagnostic performance of segmental T1 mapping as a marker of 
LGE TEI and myocardial viability in patients with previous MI (acute and chronic). Overall 
native segmental T1 mapping had an excellent diagnostic accuracy, in distinguishing viable 
from non-viable myocardium when using LGE ≥75% transmurality as a reference standard to 
define infarcted non-viable myocardium. Diagnostic accuracy was better when used in 
chronic MI (AUC -0.88) rather than acute MI (AUC -0.83). The clinical value of T1 mapping 
lies in the evaluation of myocardial scar extent, on a voxel-wise basis, without the need to 
use a contrast agent.  
 
Myocardial infarction is a regional disease affecting parts of the myocardium supplied by the 
occluded/stenosed coronary artery. Segmental analysis as per the AHA nomenclature is the 
most widely used cardiac imaging technique in current clinical practice. The study was 
designed to look at the T1 profile in different LGE TEI. In a segment wise analysis for T1 
there was a statistically significant positive correlation between LGE TEI and the native T1 
  
values. The association of native T1 and viability/TEI remained significant even adjusting for 
segments from same patient bias as well as same segment locations from different patient 
bias using the mixed effect model with random intercepts. 
 
The opportunity to correlate presence and potential extent of infarction/scarring without 
the use of a contrast agent is clinically attractive. The T1-mapping as a single criterion 
demonstrated around 88% sensitivity, specificity in differentiating viable from nonviable 
myocardium in chronic MI. Our results were similar to the study by Ferreira et al looking at 
the accuracy of T1-mapping in delineating the extent and patterns of acute myocarditis.(20)  
It may be possible in future to perform a contrast-free CMR protocol using cine and T1-
mapping for the assessment of TEI.  
 
Viability assessment is a common indication for CMR not only in chronic IHD but also in 
acute MI. The latest ESC guidelines on management of STEMI recommend viability 
assessment in an acute setting in selected cases (including in multivessel disease). (21) In 
addition to a chronic MI group our study included an acute MI group thereby giving an 
opportunity to delineate the native T1 findings in acute MI patients.  
 
The study delineated a higher accuracy of native T1 in chronic MI compared to acute for the 
assessment of viability. The reason behind the lower performance of native T1 in acute MI is 
most likely due to its pathophysiologic difference with chronic MI. Acute MI is characterised 
by oedema, loss of cell membrane integrity, an inflammatory response, necrosis, micro-
vascular obstruction (MVO) and haemorrhage whereas chronic MI by scar tissue/fibrosis in 
the extracellular space. Our study showed that the mean area at risk (oedematous area) in 
  
acute MI was 31% of LV which was significantly higher than the mean infarct size (21% of 
LV). The myocardial oedema delineated may have impacted on the performance of T1 
mapping in acute MI.  T1 mapping is influenced by all of these characteristics however LGE is 
not (especially oedema). In acute phase even LGE based TEI have been shown to be 
inaccurate(22) and hence may pose a limitation as a marker of viability/functional recovery. 
Beek et al demonstrated that 25% of segments with 75% to 100% TEI in acute MI had 
functional improvement at 13 weeks. (23)  
 
Our study was performed on 1.5T scanner but the results were comparable to the study by 
Kali et al (8) in which they reported the diagnostic accuracy of T1-mapping in the detection 
of transmurality in chronic MI. Our study included both acute and chronic MI, thereby 
helping to compare the native T1 mapping findings in the 2 groups. Our main aim was to 
assess the significance of segmental native T1 as a discriminator between viable and non-
viable myocardium unlike the study by Kali et al where they compared the overall 
transmurality between LGE and T1 mapping using thresholding technique. The native T1 
value trends in the different infarct characteristics in acute and chronic MI in our study were 
comparable to the case series published by Dall’Armelina et al, although the actual values 
were different as her study was performed on 3T and ours at 1.5T.(24) A further study on 
native T1 in acute MI by Dall’Armellina et al. showed a strongly positive correlation between 
T1 value and the LGE TEI, but they excluded segments with MVO in the analysis. (25) The 
aim of our study was to assess viability without the use of contrast. It is very difficult to 
accurately identify MVO based on the T1 mapping alone without LGE imaging. In the study 
by Bulluck et al the diagnostic accuracy of T1 maps to identify MVO was 79-81% (26). Hence 
  
in our study design the segmental native T1 analysis was done blinded to LGE data without 
excluding MVO.  
Overall global native T1 showed a significant positive correlation with infarct size and LV 
ejection fraction. However, when the analysis was done for the acute and chronic groups 
the correlation was stronger in chronic compared to acute MI. The global native T1 did not 
correlate with LVEF in acute MI, again this is likely due to the effect of MVO or 
intramyocardial haemorrhage which reduces the T1 relaxation time. 
Our study was performed on a 1.5T scanner, which is the most widely used machine. We 
have also shown a significant correlation at an individual coronary territory level. The T1 
analysis was done from the T1 maps which were available immediately on the scanner 
console with no need for further post-processing. Apical slices were not excluded from 
analysis unlike other similar studies on T1 mapping due to the potential for partial volume 
artefact. (27) Similar studies have often eliminated lateral wall infarcts due to off-resonance 
artefact, but this is less relevant at 1.5T compared to 3T. (27)  Moreover, our study sample 
had infarcts in all the different coronary territories including the lateral wall (which we 
included) to reduce the selection bias and reflect real world practice, whilst most of 
previous studies mainly included LAD infarctions.  
 
 
Study Limitations 
This is a single centre, single vendor study with a limited sample size. However, our findings 
were highly statistically significant. Larger multicenter, multivendor studies are warranted to 
confirm this proof of concept study. TEI on LGE imaging was used as the reference standard 
for viability rather than functional recovery which was used in other studies. TEI <75% was 
  
used as the marker of viability in keeping with contemporary clinical practice. The acute and 
chronic MI cohorts were completely separate in our study unlike other studies. However, 
the study design was specifically constructed to remove any repeat measure from the same 
patient bias. Peri-infarct grey-zone on LGE, which has been shown be associated with 
arrhythmic events, was not assessed.  This may have explained the difference between 
acute and chronic MI.  
 
Conclusions  
Native T1 mapping correlates significantly with TEI thereby differentiating between normal, 
infarcted viable, and infarcted non-viable myocardium with distinctive T1 profiles in both 
chronic and acute MI. Native T1 mapping performed better in chronic MI compared to acute 
due to the absence of myocardial oedema and microvascular obstruction.  T1 mapping holds 
promise for viability assessment without the need for gadolinium contrast agents.  
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Figure legends: 
Figure 1: CMR images from a 54 year old with acute transmural myocardial infarction in 
right coronary artery, 1a) T1 map of the short axis, 1b) Region of interest drawn in each of 
the segment with corresponding native T1 value (blinded to LGE image), 1c) LGE image in 
the short axis, 1d) T1 map of the corresponding short axis with region of interest in the 
remote myocardium and infarct core(unblended to LGE image) 
  
Figure 2: a) Scatter plot: chronic MI cohort showing native T1 value vs the TEI, 2b) Bar 
diagram with error bar(SD): Chronic MI cohort showing segmental native T1 value in LGE 
negative, LGE positive with viability and LGE segments with non-viability 2c) Scatter plot: 
Correlation between segmental T1 and Transmural extent of Infarct – as per coronary artery 
territory in chronic MI 2d) ROC curve: Chronic MI cohort comparing segmental native T1 vs 
LGE viability 
 
Figure 3: a) Scatter plot: Acute MI cohort showing native T1 value vs the LGE TEI, 3b) Bar 
diagram with error bar(SD): Acute MI cohort showing segmental native T1 value in LGE 
negative, LGE positive with viability and LGE segments with non-viability 3c) Scatter plot: 
Correlation between segmental T1 and Transmural extent of Infarct – as per coronary artery 
territory in acute MI 3d) ROC curve: Acute MI cohort comparing segmental native T1 vs LGE 
viability 
 
Figure 4: Boxplot showing the global native T1 in acute MI cohort, chronic MI cohort and the 
normal healthy volunteer 
  
Figure 5: a)Scatter plot showing the correlation between global T1 and infarct size, 4b) 
Scatter plot showing the correlation between global T1 and LV ejection fraction 
 
Table:  
Table 1: Demographic/CMR characteristics table 
Table 2: Mean Native T1(in ms) in the LGE negative segments, LGE positive but viable 
segments, LGE positive non-viable segments, Infarct core and Remote myocardium 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 1: 
Characteristics Control 
(n=20) 
Acute MI 
(n=30) 
Chronic MI 
(n=30) 
p-value 
(acute vs 
chronic) 
Age, years 57(±13) 61(±10) 67(±10) 0.017 
Female Sex, %  25% 20% 20% 1.0 
Smoking, %  - 27 17 0.356 
Hypertension, % - 43 53 0.447 
Diabetes, % - 10 23 0.171 
CMR 
    
LV EF % 66(±7) 51(±9) 51(±13) 0.833 
EDV ml 146(±35) 152(±29) 167(±56) 0.218 
ESV ml 51(±18) 77(±26) 85(±48) 0.406 
SV ml 95(±22) 75(±13) 83(±23) 0.144 
Infarct size % - 21(±10) 16(±12) 0.135 
 
 
 
 
 
 
  
Table 2: 
Category LGE 
negative 
segments 
LGE 
positive 
viable 
segments 
LGE 
positive  
non-viable  
segments 
Infarct  
core 
Remote 
myocardium 
Chronic 
MI 
Mean 
T1(ms) 
±SD 
 
 
1031±31 
 
1103±57 
 
1206±118 
 
1171±76 
 
1005±19 
Acute MI 
Mean 
T1(ms) 
±SD 
 
 
1054±65 
 
1135±73 
 
1168±71 
 
1308±71 
 
1054±65 
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